Literature DB >> 22654292

The current seroprevalence of hepatitis C virus in a tertiary care centre in vellore, Tamil Nadu.

V Gowri1, C Chandraleka, R Vanaja.   

Abstract

Entities:  

Year:  2012        PMID: 22654292      PMCID: PMC3361801          DOI: 10.4103/0970-0218.96110

Source DB:  PubMed          Journal:  Indian J Community Med        ISSN: 0970-0218


× No keyword cloud information.
Sir, In India about 20 million people are known to have Hepatitis C virus (HCV) infection(1) and a quarter of them expected to develop chronic liver disease in the next 10-15 years. The impact of this infection has just started to emerge in India. In the absence of efficient anti-HCV screening in our country, the HCV infection from various sources will continue to add to the disease pool. In order to know the status of HCV infection in Vellore (Northern Tamil Nadu), 2227 serum samples were screened using the third-generation ELISA (Microlisa), random samples were taken from various representative groups. 1565 samples were taken from voluntary blood donors (care was taken to exclude professional/commercial blood donors), 164 from antenatal women, 310 from STD clinic attendees, and 188 from the Human immunodeficiency virus (HIV)-positive patients enrolled for ART. HIV-positive patients were included so as to study the HIV-HCV co-infection. Among the 2227 serum samples screened, 0.22% (5/2227) were positive for anti-HCV antibodies. The positive samples were confirmed by repeat assay. A prevalence rate of 0.22% was observed on the whole in the various groups. The seroprevalence of HCV varied from one group to another. In voluntary blood donors, 0.13% (2/1565) was detected; seropositivity was still lower (0.13%) than that reported from Madurai(2) (0.75%). In STD clinic attendees, it was 0.32% (1/310). This was however low in comparison to studies from JIPMER(3) and Agra,(4) which recorded a seroprevalence rate of 6% and 1%, respectively. There were no positives detected among the 164 antenatal women. Though Delhi study reported a prevalence of 1.03%,(5) our study correlated with Simla(6) study. The rate of HIV-HCV coinfection in the present study was 1.06%. In comparison with western data,(7) this was very low. Three recent studies on HCV-HIV coinfection from India have reported a prevalence of 3.02% in Andhra Pradesh,(8) 2.2% in Tamil Nadu,(9) and 1.6% in Lucknow.(10) HCV would be responsible for emerging infection in India whose long-term implications will be felt in the decades to come. Though the prevalence rate of HCV and HCV-HIV coinfection was low in the present study, it was still a warning about the rising profile of the virus in apparently healthy individuals with the consequent risk of transmission of the virus unknowingly. The need for better prevention by health education and screening for HCV in collaboration with public health authorities becomes mandatory. So in the present study, a preliminary report on the current prevalence of the HCV in our tertiary care centre has highlighted the need for further research in this field.
  10 in total

1.  Relative prevalence of hepatitis B viral markers and hepatitis C virus antibodies (anti HCV) in Madurai, south India.

Authors:  S Chandrasekaran; N Palaniappan; V Krishnan; G Mohan; N Chandrasekaran
Journal:  Indian J Med Sci       Date:  2000-07

2.  Hepatitis C virus activity in Shimla - a preliminary report.

Authors:  S A Ganju; A Goel
Journal:  Indian J Med Microbiol       Date:  2001 Oct-Dec       Impact factor: 0.985

3.  High prevalence of hepatitis C virus infection and genotype distribution among general population, blood donors and risk groups.

Authors:  Mohammed N Khaja; Chandra Madhavi; Rekha Thippavazzula; Farees Nafeesa; Aejaz M Habib; Chittoor M Habibullah; Ramareddy V Guntaka
Journal:  Infect Genet Evol       Date:  2005-06-28       Impact factor: 3.342

4.  HIV, HBV, HCV, and syphilis co-infections among patients attending the STD clinics of district hospitals in Northern India.

Authors:  T Hussain; K K Kulshreshtha; Shikha Sinha; V S Yadav; V M Katoch
Journal:  Int J Infect Dis       Date:  2006-05-04       Impact factor: 3.623

5.  Low prevalence of hepatitis B virus and hepatitis C virus co-infection in patients with human immunodeficiency virus in Northern India.

Authors:  A K Tripathi; M Khanna; N Gupta; M Chandra
Journal:  J Assoc Physicians India       Date:  2007-06

6.  Coinfection of hepatitis B and hepatitis C virus in HIV-infected patients in south India.

Authors:  Shanmugam Saravanan; Vijayakumar Velu; Nagalingeswaran Kumarasamy; Subhadra Nandakumar; Kailapuri Gangatharan Murugavel; Pachamuthu Balakrishnan; Solomon Suniti; Sadras Panchatcharam Thyagarajan
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

7.  Prevalence & risk factors for hepatitis C virus among pregnant women.

Authors:  Ashok Kumar; K Aparna Sharma; R K Gupta; P Kar; Anita Chakravarti
Journal:  Indian J Med Res       Date:  2007-09       Impact factor: 2.375

8.  Morbidity and mortality profile of human immunodeficiency virus-infected patients with and without hepatitis C co-infection.

Authors:  Angel M Mayor; Maria A Gomez; Diana M Fernandez; Eddy Rios-Olivares; James C Thomas; Robert F Hunter
Journal:  Am J Trop Med Hyg       Date:  2006-02       Impact factor: 2.345

9.  Co-infection with hepatitis C virus and human immunodeficiency virus among patients with sexually transmitted diseases in Pondicherry, South India.

Authors:  S Bhattacharya; S Badrinath; A Hamide; S Sujatha
Journal:  Indian J Pathol Microbiol       Date:  2003-07       Impact factor: 0.740

10.  Prevalence of hepatitis C virus (HCV) coinfection in HIV infected individuals in south India and characterization of HCV genotypes.

Authors:  S P D Ponamgi; S Rahamathulla; Y N Kumar; M Chandra; N Lakshmi; C M Habibullah; M N Khaja
Journal:  Indian J Med Microbiol       Date:  2009 Jan-Mar       Impact factor: 0.985

  10 in total
  4 in total

1.  Most Patients of Hepatitis C Virus Infection in India Present Late for Interferon-Based Antiviral Treatment: An Epidemiological Study of 777 Patients from a North Indian Tertiary Care Center.

Authors:  Varun Gupta; Ashish Kumar; Praveen Sharma; Naresh Bansal; Vikas Singla; Anil Arora
Journal:  J Clin Exp Hepatol       Date:  2015-05-21

2.  Prevalence of antibodies to hepatitis C virus in voluntary blood donors: are women better donors?

Authors:  Dakshayani Padmakar Pandit; Pradhan Pagaro M; Chaudhury Nabamita
Journal:  J Clin Diagn Res       Date:  2014-04-15

Review 3.  Consensus Statement of HCV Task Force of the Indian National Association for Study of the Liver (INASL). Part I: Status Report of HCV Infection in India.

Authors:  Pankaj Puri; Anil C Anand; Vivek A Saraswat; Subrat K Acharya; Radha K Dhiman; Rakesh Aggarwal; Shivram P Singh; Deepak Amarapurkar; Anil Arora; Mohinish Chhabra; Kamal Chetri; Gourdas Choudhuri; Vinod K Dixit; Ajay Duseja; Ajay K Jain; Dharmesh Kapoorz; Premashis Kar; Abraham Koshy; Ashish Kumar; Kaushal Madan; Sri P Misra; Mohan V G Prasad; Aabha Nagral; Amarendra S Puri; R Jeyamani; Sanjiv Saigal; Shiv K Sarin; Samir Shah; P K Sharma; Ajit Sood; Sandeep Thareja; Manav Wadhawan
Journal:  J Clin Exp Hepatol       Date:  2014-06-09

4.  Combating the wrath of viral hepatitis in India.

Authors:  Sandeep Satsangi; Radha K Dhiman
Journal:  Indian J Med Res       Date:  2016-07       Impact factor: 2.375

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.